21 related articles for article (PubMed ID: 21752100)
1. Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation.
Liu H; Zeng L; Yang Y; Guo C; Wang H
Front Immunol; 2022; 13():847699. PubMed ID: 35355979
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.
Morales-Martinez M; Valencia-Hipolito A; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Martinez-Maza O; Huerta-Yepez S; Vega MI
Oncotarget; 2019 Mar; 10(22):2173-2188. PubMed ID: 31040909
[TBL] [Abstract][Full Text] [Related]
3. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development.
Mazan-Mamczarz K; Zhao XF; Dai B; Steinhardt JJ; Peroutka RJ; Berk KL; Landon AL; Sadowska M; Zhang Y; Lehrmann E; Becker KG; Shaknovich R; Liu Z; Gartenhaus RB
PLoS Genet; 2014 Jan; 10(1):e1004105. PubMed ID: 24497838
[TBL] [Abstract][Full Text] [Related]
5. The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.
Zhang X; Paun A; Claudio E; Wang H; Siebenlist U
J Immunol; 2013 Dec; 191(12):5984-92. PubMed ID: 24244019
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".
Kusumoto S; Kobayashi Y; Sekiguchi N; Tanimoto K; Onishi Y; Yokota Y; Watanabe T; Maeshima AM; Ishida T; Inagaki H; Matsuno Y; Ueda R; Tobinai K
Am J Surg Pathol; 2005 Aug; 29(8):1067-73. PubMed ID: 16006802
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
8. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
Barrans SL; Evans PA; O'Connor SJ; Kendall SJ; Owen RG; Haynes AP; Morgan GJ; Jack AS
Clin Cancer Res; 2003 Jun; 9(6):2133-9. PubMed ID: 12796378
[TBL] [Abstract][Full Text] [Related]
9. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
[TBL] [Abstract][Full Text] [Related]
10. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
11. BCL3 rearrangement, amplification and expression in diffuse large B-cell lymphoma.
Ibrahim HA; Amen F; Reid AG; Naresh KN
Eur J Haematol; 2011 Dec; 87(6):480-5. PubMed ID: 21752100
[TBL] [Abstract][Full Text] [Related]
12. [Molecular and cytogenetic heterogeneity of diffuse large B-cell lymphoma].
Taniwaki M
Rinsho Ketsueki; 2012 Oct; 53(10):1649-55. PubMed ID: 23037737
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
